SCOPUS 정보 검색 플랫폼

Volumn 49, Issue 5, 2009, Pages 806-

Lack of evidence associating nephrotoxicity with low-dose gentamicin for staphylococcus aureus bacteremia and endocarditis

(1) Bruss, Jon B a

a Achaogen Inc (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAPTOMYCIN; GENTAMICIN; VANCOMYCIN;

CLINICAL TRIAL; ENDOCARDITIS; HUMAN; LETTER; LOW DRUG DOSE; NEPHROTOXICITY; PRIORITY JOURNAL; STAPHYLOCOCCAL BACTEREMIA; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTEREMIA; CREATININE; DAPTOMYCIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; ENDOCARDITIS, BACTERIAL; GENTAMICINS; HUMANS; KIDNEY; SAMPLE SIZE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN;

EID: 70149105519 PISSN: 10584838 EISSN: None Source Type: Journal
DOI: 10.1086/605287 Document Type: Letter

Times cited : (5)

References (6)

1
- 62449226267
- Initial low dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic
- Cosgrove SE, Vigliani GA, Campion M, et al. Initial low dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic. Clin Infect Dis 2009; 48: 713-721
- (2009) Clin Infect Dis , vol.48 , pp. 713-721
- Cosgrove, S.E.¹ Vigliani, G.A.² Campion, M.³

2
- 21444454242
- Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations
- Tsuji BT, Rybak MJ. Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations. Antimicrob Agents Chemother 2005; 49: 2735-2745
- (2005) Antimicrob Agents Chemother , vol.49 , pp. 2735-2745
- Tsuji, B.T.¹ Rybak, M.J.²

3
- 34247149253
- Activity of daptomycin alone and in combination with rifampin and gentamicin against Staphylococcus aureus assessed by time-kill methodology
- Credito K, Lin G, Appelbaum PC. Activity of daptomycin alone and in combination with rifampin and gentamicin against Staphylococcus aureus assessed by time-kill methodology. Antimicrob Agents Chemother 2007; 51: 1504-1507
- (2007) Antimicrob Agents Chemother , vol.51 , pp. 1504-1507
- Credito, K.¹ Lin, G.² Appelbaum, P.C.³

4
- 0022657174
- In vivo uptake kinetics of aminoglycosides in the kidney cortex of rats
- Giuliano RA, Verpooten GA, Verbist L, Weeden R, Debroe ME. In vivo uptake kinetics of aminoglycosides in the kidney cortex of rats. J Pharmacol Exp Ther 1986; 236: 470-475
- (1986) J Pharmacol Exp Ther , vol.236 , pp. 470-475
- Giuliano, R.A.¹ Verpooten, G.A.² Verbist, L.³ Weeden, R.⁴ Debroe, M.E.⁵

5
- 0028334016
- Attenuation by daptomycin of gentamicin-induced experimental nephrotoxicity
- Thibault N, Grenier L, Simard M, Bergeron MG, Beauchamp D. Attenuation by daptomycin of gentamicin-induced experimental nephrotoxicity. Antimicrob Agents Chemother 1994; 38: 1027-1035 (Pubitemid 24150833)
- (1994) Antimicrobial Agents and Chemotherapy , vol.38 , Issue.5 , pp. 1027-1035
- Thibault, N.¹ Grenier, L.² Simard, M.³ Bergeron, M.G.⁴ Beauchamp, D.⁵

6
- 0028902974
- Protection against gentamicin nephrotoxicity by daptomycin in nephrectomized rats
- Thibault N, Grenier L, Simard M, Bergeron MG, Beauchamp D. Protection against gentamicin nephrotoxicity by daptomycin in nephrectomized rats. Life Sci 1995; 56: 877-887
- (1995) Life Sci , vol.56 , pp. 877-887
- Thibault, N.¹ Grenier, L.² Simard, M.³ Bergeron, M.G.⁴ Beauchamp, D.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.